Pediatrics Strabismus News

Meibomian gland dysfunction is not an adults-only disease, and when the combination of inflammation of the eyelids, conjunctiva and cornea is prolonged in children, the corneal consequences and effect on vision can be severe.

QR-421a has received rare pediatric disease designation from the FDA for the treatment of retinitis pigmentosa, according to a press release from ProQR Therapeutics.

Myopia progression is a hot topic in pediatric ophthalmology, whether the treating physician uses atropine, surgical procedures or contact lenses.

KOLOA, Hawaii — At Hawaiian Eye 2020, Jack T. Holladay, MD, MSEE, discusses research he has been examining to reduce the global progressive myopia epidemic, looking at the use of prisms, as well as performing cross-linking of the sclera.

Clinicians may see dry eye in some adolescents and should monitor their meibomian glands for dropout and other signs of meibomian gland dysfunction, according to a study assessing expected values from common ocular surface diagnostic measures.

In children with congenital nasolacrimal canal dysplasia, the combination of endoscopic dacryocystorhinostomy and lacrimal CT scan may be advantageous over traditional solutions, according to retrospective study.

Esports is quickly becoming one of the most popular global pastimes to play and watch, with its estimated audience already surpassing that of Major League Baseball.

Using a mask to decrease photosensitivity following screening for retinopathy of prematurity reduced stress in the infants after the examination, according to study.

The first contact lens indicated to slow myopia progression in children aged 8 to 12 years has received FDA approval, according to an FDA press release.

Like any other part and function of the body, the eye and vision change over time. In the last two decades, advanced solutions have been developed to meet the needs of individuals at each stage of this process, allowing them to maintain healthy eyesight and enhance quality of life through spectacle-free vision. With such a wide spectrum of options available, it makes sense now to overcome fragmentation and give patients what they need at different stages of ocular maturity within the framework of a lifetime plan for vision.